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We evaluated TRC4 primers using polymerase chain
reaction (PCR) which amplify a new target sequence
from Mycobacterium tuberculosis genome to diagnose
tuberculous lymphadenitis and compared the results
with PCR using the widely used IS6110 primers. The
PCR results were also compared with conventional
methods like smear, culture and histopathology. The
sensitivity of PCR using both probes is higher than the
conventional methods. Out of 101 samples analysed
(49 fresh and 52 fixed specimens), PCR using IS6110
and TRC4 primers was positive in 64 and 70 samples,
respectively, whereas results with culture and histo-
pathology methods were positive only in 49 and 58
samples, respectively. The problem of false negativity
of IS6110 due to the absence of IS6110 copy in 4
M. tuberculosis isolates was overcome by using TRC4
primers. The results indicate that with improvement in
PCR techniques, PCR using both probes, IS6110 and
TRC4 can be a rapid and sensitive adjunct to conven-
tional techniques in the diagnosis of tuberculous
lymphadenitis.
TUBERCULOSIS (TB) has been gaining much interest in
recent years due to the pandemic of human immunodefi-
ciency virus, which is a significant risk factor for the
development of tuberculosis1. Conventional methods of
detecting mycobacteria in clinical samples, especially in
extrapulmonary TB are either low in sensitivity and speci-
ficity or are time consuming. There is an urgent need for
developing newer tools for the rapid diagnosis of TB.
In India, where the incidence of TB is high, TB lymph-
adenitis continues to be one of the most frequent causes of
lymphadenopathy 30-52% (ref. 2). Cervical lymphnode
involvement is the most common form and accounts for
70% of all the lymphnode TB2. Diagnosis is usually esta-
blished by demonstrating mycobacteria either by histo-
pathology or on smears subjected to acid fast stains.
Histopathology revealing caseating granulomas is highly
suggestive of mycobacterial infection but other factors
may product similar histology. Culture takes 4 to 8 weeks
for detection of the organism.
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The detection of M. tuberculosis by polymerase chain
reaction (PCR) has been found to be useful in the diagno-
sis of extrapulmonary and pulmonary TB. Several target
sequences have been described to detect M. tuberculosis 3-8
that include the rRNA genes2,9, single copy genes encoding
structural proteins of 65 and 38 kD (refs 10-12), insertion
element IS6110 (ref. 13), and dnaJ gene14. The sensitivi-
ties and specificities using various targets varied from 60
to 100%.
The most widely used primers to detect M. tuberculosis
in clinical specimens by PCR are from the insertion ele-
ment IS6110. We previously reported that 40% of the
Madras strains carried only a single copy of IS6110 and
4% did not carry even a single copy of IS6110 (ref. 15).
Since IS6110-based PCR for diagnosis may in some 
cases lead to false negative results, we developed a new
target for PCR using repetitive element, TRC4. This is a
conserved sequence and repeats at least four times in the
genome of M. tuberculosis 16. Our previous study using
RFLP showed that TRC4 was present in all the 200
M. tuberculosis strains analysed16 (unpublished data). It
was also present in the strains which did not harbour the
IS6110 copy. Since the TRC4 fragment is a conserved
repeat element present in all the strains, WC consider it to
be a valuable target for diagnostic PCR. From the dedu-
ced sequence of 2.126 kb to TRC4 several primer pairs
have been designed and one set of primers amplifies a
target sequence of 173 bp consistently. The specificity of
TRC4 has been analysed using slot blot hybridization16,
Southern blot hybridization with radioactively labelled
TRC4, PCR amplification of non-mycobacterial species
and atypical mycobacteria using primers which amplify
173 bp product (unpublished observation).
In the present study we evaluated PCR using IS6110
and TRC4 (new target) to detect M. tuberculosis from
lymphadenitis specimens and compared the results with con-
ventional bacteriological and histopathologicnl methods.
We did a prospective study on 49 fresh lymphnode
specimens from 49 patients. The Department of Patho-
logy, Kilpauk Medical College, Chennai, provided the
above samples. These fresh specimens were coded and
each lymphnode was cut into small pieces. These small
pieces were randomly allocated for smear, culture, histo-
pathology and PCR.
A retrospective study was done on 52 formalin-fixed
paraffin-embedded tissues from 52 patients included in a
study conducted during 1983-1993 by the Department of
Pathology, Tuberculosis Research Centre, Chennai.
For histopathological studies, a portion of the fresh
lymphnode was fixed in 10% formalin, processed rou-
tinely and stained with haematoxylin and eosin (H and E).
The sections were also stained by the Ziehl-Nielson (ZN)
method for acid fast bacilli.
Histologically TB was diagnosed when a nectrotizing,
caseating granuloma surrounded by epithelioid cells, lym-
phocytes, plasma cells and giant cells was seen.
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For microscopic studies, lymphnode specimens were
cut into small pieces using sterile scissors and forceps.
5.0 ml of sterile distilled water was added and homo-
genized using an electrical homogenizer. One loopful of
this concentrated mixture was taken for smear. The slides
were examined by auramine-rhodamine fluorochrome
staining.
For culture, the aseptically homogenized lymphnode
sample was centrifuged, the supernatant was discarded,
the deposit was decontaminated using 5% sulphuric acid
and was resuspended in 7 ml of selective Kirchner’s liquid
medium (KL)17 and cultured for mycobacteria in multiple
media. The culture media used were Lowenstein-Jenson
(LJ) medium, LJ medium containing 0.5% sodium pyru-
vate (LJP), 7H11 oleic acid (Difco Laboratories), albumin
agar with malachite green (Difco) and Kirchner’s liquid
medium (KL).
For the retrospective study, DNA from fresh tissue was
extracted using the method of Wilson18 with slight modi-
fication. Thin sections of paraffin-embedded lymphnodes
were dewaxed by adding 400 µl of xylene in an eppendorf
tube. The specimens were rehydrated sequentially in
100, 80, 70 and 50% ethanol for 10 min with centrifuga-
tion after each step of rehydration. After rehydration,
the specimen was processed by the CTAB method as
mentioned earlier.
A 173 bp region from the repetitive sequence, cloned
and identified in our laboratory was selected for ampli-
fication on the basis of specificity analysis. Hot start PCR
was carried out in a 25 µl volume in 50 mM KCI, 10 mM,
Tris-HCl (pH 8.3), 1.5 mM MgC12, 0.01% (w/v) gelatin,
0.5 µM of oligonucelotide primers TRC Pril and TRC Pri2
(patent pending), or IS6110 primers, (a) 5'CCTGCGAG-
CGTAGGCGTCGG3'; (b) 5'CTCGTCCAGCGCCGCT-
TCGG3', 200 mM of four dNTPS, 0.5 U Taq DNA
polymerase (Amersham, UK) and the DNA from clinical
specimens. The reactions were subjected to amplification
with the following profile 1' at 96°C, 1' at 58°C and 1' at
72°C for 35 cycles. A negative control (consisting of all
the reaction components except the DNA template), a
processing control (water blank included during the ex-
traction of DNA from the sample) and a positive control
(50 ng of M. tuberculosis H37Rv DNA) were included in
every assay. After amplification, an aliquot of PCR reac-
tion was analysed on 2% agarose gel. After visualization
with ethidium bromide, the DNA was blotted onto nylon
membrane by the vacuum blotting method (Hoefer Instru-
ments, USA). The amplified product or the whole target
sequence of positive control was labelled with horse rad-
ish peroxidase and used to probe the immobilized, ampli-
fied products.
Stock solutions (including those required for the pro-
cessing of the sample for DNA extraction) were prepared
with millipore filtered, sterile water. These were prepared
in a separate room, aliquoted, autoclaved, stored and used
only once. Chemical decontamination of surfaces (daily)
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and equipment (weekly) was done with 0.5% sodium hypo-
chloride and 70% ethanol. Prevention of DNA contami-
nation was further accomplished by physically separating
the different steps of the PCR procedure, using separate
set of pipettes and tips.
Out of 101 lymphnode specimens included in this
study, 49 were fresh lymphnode specimens (unfixed) and
52 were fixed and paraffin-embedded specimens. These
samples were coded and taken for PCR analysis.
Positive samples and positive controls produced DNA
bands of 123 bp with the IS6110 primers and 173 bp with
TRC4 primers (Figure 1). All clinical, samples that gave
123 bp and 173 bp fragments on ethidium bromide stained
agarose gels were also positive by Southern hybridization
with the respective probes. The detection limit of PCR
using TRC4 primers was earlier tested using dilutions of
genomic DNA purified from M. tuberculosis. Reactions
were adjusted such that they contained 5 x 107-1 genome
equivalent (5 fg of DNA is approximately 1 genome equi-
valent). PCR was able to detect as few as 1 genome
equivalent by agarose gel electrophoresis and Southern
hybridization (data not shown). Hybridization increased
neither the specificity nor the sensitivity in our study.
Comparison of the results from bacteriological exami-
nation, histopathology and PCR is shown in Table 1. Out
of 101 samples, only 11 were positive by smear micro-
scopy. Culture and histopathology were positive in 49 and
58 samples, respectively. PCR using IS6110 and TRC4
primers was positive in 64 and 70 samples, respectively.
A higher percentage of positives has been obtained with
PCR in fresh lymphnode specimens than histopathology,
when compared to PCR from fixed specimens.
Figure  1 . PCR amplification of clinical samples using TRC4 and
IS6110 primers. Lane I, Negative control (no DNA) with TRC4 pri-
mers; Lane 2, positive control (M. tuberculosis H37Rv DNA) with TRC4
primers amplifying 173 bp product; Lane 3, positive control (M. tuber-
culosis H37Rv DNA) with IS6110 primers amplifying 123 bp product;
Lane 4, negative control (no DNA) with IS6110 primers; Lane 5,
molecular weight marker (Hind III); Lane 6, processing control with
TRC4 primers (water blank included during of the clinical sample);
Lane 7, a negative clinical sample (with TRC4 primers); Lanes 8 to 11,
clinical samples which show 173 bp; Lane 12, processing control with
IS6110 primers (water blank included during processing of the clinical
 sample); Lanes 13 to 16, positive clinical samples which show 123 bp
product.
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Table 1. Comparison of final diagnosis with results from bacteriological examination, histopathology and PCR
No. of specimens positive by
PCR
No. of Smear Histo-
Type of specimen patients microscopy Culture pathology IS6110 TRC4
Fresh lymphnode 49 9 21 22 32 35
Formalin-fixed paraffin- 52 2 28 36 32 35
embedded specimens
Among the 101 samples included in the analysis, results
for pathology and culture were not available for samples,
1 and 6 respectively. The summary of the analysis is
shown in Table 2. Out of these, twenty-eight were positive
by culture, histopathology and PCR using two probes.
Thirteen samples were negative by all the above criteria,
and 12 samples which were positive by culture and histo-
pathology were also positive with either of the probe.
Eight samples which were negative by culture and histo-
pathology were also negative by one of the probes. Eight
samples which were positive by PCR using both the
probes were positive by either culture or histopathology.
The agreement of PCR using IS6110 and/or TRC4 with
either culture or histopathology was 79%. The two probes
classified 14 samples as positive, which were negative by
culture and histopathology. Among these, 3 samples were
from patients with strong clinical evidence of TB, and two
samples were from patients with past history of treatment
for TB. Six samples were false negative by both probes
and positive by both culture and histopathology. Three
samples were negative by PCR and positive by either
culture or histopathology. Two samples were negative by
PCR using IS6110 and culture, positive by PCR using
TRC4 primers and histopathology.
There has been disagreement between the various crite-
ria used for diagnosis. The smear results have not been
included in this analysis because they have very low
sensitivity. Culture and histopathology differed in 13 sam-
ples. Eleven samples were called negative by culture but
positive by histopathology and 2 samples vice versa. Simi-
larly there has been discordance between the two probes.
Among the 22 samples in which the PCR results diff-
ered between the two sets of primers, 14 were positive
using TRC4 primers but were negative by IS6110 pri-
mers. Four out of the above 14 samples were negative by
culture and histopathology. Hence the actual false nega-
tives by IS6110 are 10. These 10 strains were once again ana-
lysed for the presence of IS6110 copy by performing PCR
using DNA extracted from the culture of the respective
clinical isolate. Out of 10 samples, 4 samples did not have
the IS6110 copy. Six false negativity of IS6110 was
partially due to the absence of IS6110 from 4 of the TB
isolates.
Among the 8 strains which were positive by IS6110 and
negative by TRC4 primers, 4 samples were negative by
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Table 2. Comparative evaluation of PCR and conventional methods
PCR
Histo- No. of
Culture pathology IS6110 TRC4 samples
+ + + + 28
13
+  + + 4

















Positive. (+); Negative. (-); NA. not available; ND, not done.
smear, culture and histopathology. Only 4 were false
negative by TRC4 primers in contrast to 10 false nega-
tives by IS6110 primers.
If we use culture as the standard method and calculate
sensitivity, TRC4 primers have a sensitivity of 86% with
fresh specimens and 78% with all specimens (fresh and
fixed) which is better than IS6110 primers with a sensi-
tivity of 76% in fresh and 69% in all specimens. This is
not statistically significant. McNemar’s test was used for
comparison of the probes.
Extrapulmonary manifestations of TB need early and
sensitive diagnosis even though it is three times less fre-
quently encountered than pulmonary TB (ref. 19). Con-
ventional procedures to detect M. tuberculosis are low in
sensitivity due to the low number of infecting organisms.
Nucleic acid amplification procedures allow rapid detec-
tion of M. tuberculosis from clinical specimens. PCR is
difficult to be incorporated in clinical laboratories on a
routine basis because of the extreme care and precaution
demanded by the technical steps involved. Nevertheless,
the high degree of sensitivity and rapidity render a posi-
tive PCR result clinically useful and there is ample scope
to improve the methodology.
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In the present study we have used a new target (TRC4)
for enzymatic amplification to detect M. tuberculosis
from suspected lymphnode specimens. The TRC4 primers
amplify a 173 bp product. It has already been shown that
the longer the amplified fragment, the higher the likeli-
hood of degradation and thus lower the efficacy of the
amplification itself20,21. Although we designed several
primer pairs from the repetitive element (TRC4), which
amplify various lengths of the product, we chose Pri1 and
Pri2 which gave a consistent 173 bp in a preliminary
study. There have been very few studies on PCR in TB
lymphadenitis22,23. In this study we compared PCR using 2
probes with conventional methods like culture and histo-
pathology and also compared the sensitivity of PCR in
fresh versus paraffin-fixed specimens.
Among the conventional tests chosen, the sensitivity
of microscopy has been very low and already it is
known that this method has a detection limit of 104 myco-
bacteria per sample8. Even though culture is considered
good standard its sensitivity is low in extrapulmonary-TB
due to the paucibacillary nature of the specimen. PCR
is able to detect M. tuberculosis in such paucibacillary
specimens.
Apart from the false negativity problems encountered
with PCR techniques, the lack of IS6110 copies in some
of the strains also contributed to the false negativity which
has been overcome by TRC4 primers. TRC4 has been
found to be better in sensitivity (statistically not signifi-
cant) than IS6110 especially in detecting IS6110 negative
strains in this study. The false negative results could have
resulted from the presence of inhibitors not detected by
control amplification and non homologous distribution of
bacteria in the specimen, so that the fraction tested does
not contain mycobacteria. These reasons could justify the
false negativity observed with both the probes in 6 out of
94 samples. The reason for false negative results in 14
samples with either of the two set of primers is not known.
To minimize this discrepancy, more than one specimen
from each patient has to be tested just like culture. PCR
also should be repeated twice with the same specimen for
confirmation when there is a difference in the results of
the two probes.
Marchelti et al. 24 have reported that the concentration
of DNA used affected the outcome of the amplification
protocols considerably. It has been reported that the eff-
ectiveness of PCR with formalin-fixed paraffin-embedded
tissue is impaired by multiple interacting factors including
the type of fixative used25. Our results also are in agree-
ment with those of Greer et al. 25, that the sensitivity of
PCR using both probes TRC4 and IS6110 was lower in
paraftin-embedded specimens than in fresh lymphnode
specimens.
The present study indicates that with improvements in
PCR techniques, the PCR with both probes IS6110 and
TRC4 can be used as a fast and sensitive adjunct to other
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